FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

764617004: Halobetasol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3653923014 Halobetasol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3653924015 Halobetasol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Halobetasol Is a Synthetic glucocorticoid, fluorinated false Inferred relationship Some
Halobetasol Is a Fluorinated corticosteroid true Inferred relationship Some
Halobetasol Is a Glucocorticoid (substance) true Inferred relationship Some
Halobetasol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing halobetasol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 1
Halobetasol propionate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Halobetasol Inferred relationship Some
Product containing only halobetasol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 1
Product containing halobetasol and tazarotene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 2
Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 2
Halobetasol only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 1
Halobetasol and tazarotene only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 2
Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 2
Product containing halobetasol in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Halobetasol Inferred relationship Some 1

This concept is not in any reference sets

Back to Start